umu.sePublications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Hög överlevnad efter barncancer, ibland till högt pris: [High survival after childhood cancer, sometimes at a high price]
Show others and affiliations
2010 (Swedish)In: Läkartidningen, ISSN 0023-7205, E-ISSN 1652-7518, Vol. 107, no 42, 2572-2575 p.Article in journal (Refereed) Published
Abstract [sv]

I dag lever 80 procent av patienterna med cancer i barn- och ungdomsåren fem år efter diagnos.

Ungefär 6 000–7 000 individer i Sverige är före detta barncancerpatienter.

Sena komplikationer till sjukdom och behandling ses hos 60–70 procent av överlevarna.

Extra utsatta är de med hjärntumör, de som strålbehandlats och vissa grupper som stamcellstransplanterats.

Inte alla som behandlats för cancer i barn- och ungdomsåren drabbas av sena komplikationer.

En kohortstudie bestående av alla i Norden som under 20 års ålder insjuknade i cancer (n ≈55 000) åren 1943–2008 har påbörjats 2010.

Riktlinjer för uppföljning efter barncancer baserat på given behandling har tagits fram av Svenska arbetsgruppen för långtidsuppföljning efter barncancer (SALUB).

Abstract [en]

The 5-year survival for children and adolescents with cancer in developed countries is now 80 % and as a result of this, the number of adults who were treated for cancer in childhood is steadily increasing. Studies have shown that 60-70 % of survivors have at least one late complication after their disease and/or its treatment, with as yet no plateau in increased incidence. Most affected are survivors of brain tumours, those who received radiation therapy and some groups of survivors after stem cell transplantation. Problems include increased late mortality, second malignant neoplasms, endocrinological matters including infertility, cardiac and pulmonary issues and neurocognitive problems. A Nordic cohort study (Nordic Childhood Cancer Study, NCCS) is starting 2010 with the largest number of survivors yet followed. Recommendations for follow-up have been produced in North America and the United Kingdom and for Sweden by the working group for long-term follow-up after childhood cancer (SALUB).

Place, publisher, year, edition, pages
Stockholm: Sveriges läkarförbund , 2010. Vol. 107, no 42, 2572-2575 p.
Keyword [sv]
Tumörer, Barn, Ungdomar, Vuxna, Sjukdomsfri överlevnad, Sjukdomsbörda, Uppföljningsstudier
National Category
Cancer and Oncology Pediatrics
Identifiers
URN: urn:nbn:se:umu:diva-39275PubMedID: 21137552OAI: oai:DiVA.org:umu-39275DiVA: diva2:389985
Available from: 2011-01-20 Created: 2011-01-20 Last updated: 2017-12-11Bibliographically approved

Open Access in DiVA

No full text

Other links

PubMedhttp://www.lakartidningen.se/07engine.php?articleId=15225

Search in DiVA

By author/editor
Melin, BeatriceSandström, Per-Erik
By organisation
OncologyPaediatrics
In the same journal
Läkartidningen
Cancer and OncologyPediatrics

Search outside of DiVA

GoogleGoogle Scholar

pubmed
urn-nbn

Altmetric score

pubmed
urn-nbn
Total: 396 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf